Price movement over the last 24 hours
Abbott Laboratories vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Abbott Laboratories trades at $95.4 (market cap $166.94B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $23.23. The key difference: Abbott Laboratories pays a 2.63% dividend while ProShares UltraShort Bloomberg Natural Gas ETF pays none. Which is the better fit depends on your goals.
| ABT | KOLD | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $136.62 | $49.39 |
52-Week Low | $82.57 | $13.58 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
KOLD trades at $23.29, down 0.64% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The stock faces support at $23 and resistance at $24. Recent natural gas market volatility, driven by weather patterns and LNG demand fluctuations, creates trading opportunities for this bearish natural gas ETF.
As a tactical trading instrument, KOLD offers exposure to inverse natural gas price movements amid heightened energy market volatility. Key risks include weather-driven demand shifts and geopolitical factors affecting gas prices, while the bullish technical setup suggests potential near-term upside for this specialized energy sector play.
Trailing returns across standard periods
Latest headlines on both assets
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →